Compare Piramal Healthcare with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs STRIDES PHARMA SCIENCE - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES STRIDES PHARMA SCIENCE PIRAMAL ENTERPRISES/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 17.7 24.0 74.0% View Chart
P/BV x 1.2 1.5 82.9% View Chart
Dividend Yield % 1.9 0.3 575.0%  

Financials

 PIRAMAL ENTERPRISES   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
STRIDES PHARMA SCIENCE
Mar-18
PIRAMAL ENTERPRISES/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3,3031,147 287.9%   
Low Rs1,797642 279.9%   
Sales per share (Unadj.) Rs716.5317.2 225.8%  
Earnings per share (Unadj.) Rs79.77.8 1,016.0%  
Cash flow per share (Unadj.) Rs107.925.1 430.6%  
Dividends per share (Unadj.) Rs28.002.00 1,400.0%  
Dividend yield (eoy) %1.10.2 491.2%  
Book value per share (Unadj.) Rs1,477.5274.3 538.7%  
Shares outstanding (eoy) m184.4589.50 206.1%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x3.62.8 126.2%   
Avg P/E ratio x32.0114.0 28.1%  
P/CF ratio (eoy) x23.635.7 66.2%  
Price / Book Value ratio x1.73.3 52.9%  
Dividend payout %35.125.5 137.8%   
Avg Mkt Cap Rs m470,29280,058 587.4%   
No. of employees `0007.82.5 311.9%   
Total wages/salary Rs m22,5044,341 518.5%   
Avg. sales/employee Rs Th16,899.411,325.8 149.2%   
Avg. wages/employee Rs Th2,877.71,731.4 166.2%   
Avg. net profit/employee Rs Th1,879.9280.1 671.3%   
INCOME DATA
Net Sales Rs m132,15328,394 465.4%  
Other income Rs m3,128941 332.6%   
Total revenues Rs m135,28129,334 461.2%   
Gross profit Rs m66,2903,965 1,671.7%  
Depreciation Rs m5,2021,540 337.7%   
Interest Rs m44,0971,962 2,247.1%   
Profit before tax Rs m20,1191,403 1,433.8%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m8,61197 8,850.3%   
Profit after tax Rs m14,701702 2,093.9%  
Gross profit margin %50.214.0 359.2%  
Effective tax rate %42.86.9 617.3%   
Net profit margin %11.12.5 449.9%  
BALANCE SHEET DATA
Current assets Rs m122,74224,836 494.2%   
Current liabilities Rs m310,81018,993 1,636.4%   
Net working cap to sales %-142.320.6 -691.6%  
Current ratio x0.41.3 30.2%  
Inventory Days Days2371 32.5%  
Debtors Days Days39113 34.2%  
Net fixed assets Rs m116,90434,289 340.9%   
Share capital Rs m369895 41.2%   
"Free" reserves Rs m272,16123,651 1,150.8%   
Net worth Rs m272,53024,546 1,110.3%   
Long term debt Rs m270,19615,513 1,741.7%   
Total assets Rs m856,26165,437 1,308.5%  
Interest coverage x1.51.7 84.9%   
Debt to equity ratio x1.00.6 156.9%  
Sales to assets ratio x0.20.4 35.6%   
Return on assets %6.94.1 168.6%  
Return on equity %5.42.9 188.6%  
Return on capital %12.46.9 180.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,20015,697 96.8%   
Fx outflow Rs m4,889735 664.8%   
Net fx Rs m10,31214,962 68.9%   
CASH FLOW
From Operations Rs m-115,9751,871 -6,199.5%  
From Investments Rs m-8,2655,826 -141.9%  
From Financial Activity Rs m107,525-10,157 -1,058.6%  
Net Cashflow Rs m-16,650-2,615 636.7%  

Share Holding

Indian Promoters % 52.9 27.7 191.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 37.8 10.6%  
FIIs % 26.6 8.6 309.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 25.9 63.7%  
Shareholders   93,274 56,241 165.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 225 Points Higher; Metal and Banking Stocks Witness Buying(Closing)

Extending gains to the fourth consecutive session, Indian share markets witnessed buying interest throughout the day today and ended higher.

Related Views on News

STRIDES PHARMA SCIENCE at 52 Week High; BSE 500 Index Up 0.5% (Market Updates)

Aug 11, 2020 | Updated on Aug 11, 2020

STRIDES PHARMA SCIENCE share price has hit a 52-week high. It is presently trading at Rs 628. BSE 500 Index is up by 0.5% at 14,843. Within the BSE 500, STRIDES PHARMA SCIENCE (up 2.1%) and NESCO (up 15.9%) are among the top gainers, while top losers are LAURUS LABS LTD and CAPLIN POINT.

LAURUS LABS LTD Share Price Down by 5%; BSE HEALTHCARE Index Down 1.2% (Market Updates)

Aug 11, 2020 | Updated on Aug 11, 2020

LAURUS LABS LTD share price is trading down by 5% and its current market price is Rs 1,160. The BSE HEALTHCARE is down by 1.2%. The top gainers in the BSE HEALTHCARE Index are J.B.CHEMICALS (up 4.4%) and SYNGENE INTERNATIONAL (up 1.9%). The top losers are LAURUS LABS LTD (down 5.2%) and STRIDES PHARMA SCIENCE (down 5.7%).

STRIDES PHARMA SCIENCE Share Price Down by 5%; BSE HEALTHCARE Index Down 1.1% (Market Updates)

Aug 11, 2020 | Updated on Aug 11, 2020

STRIDES PHARMA SCIENCE share price is trading down by 5% and its current market price is Rs 611. The BSE HEALTHCARE is down by 1.1%. The top gainers in the BSE HEALTHCARE Index are J.B.CHEMICALS (up 4.5%) and ERIS LIFESCIENCES LIMITED (up 2.5%). The top losers are STRIDES PHARMA SCIENCE (down 5.0%) and CAPLIN POINT (down 6.0%).

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 11, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS